Therapy News and Research

RSS

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

A new mouse model identified by virologists from the University of Pittsburgh might revolutionize development of therapies targeting brain inflammation caused by Rift Valley Fever virus (RVFV).

15 Jul 2022

Pairing phone-based smoking cessation and lung screening programs could maximize health benefits, cut costs

Integrating telephone-based smoking cessation and lung screening programs not only have the potential to maximize long-term health benefits, but they can also be cost-effective in the long term, according to a University of Michigan-led study.

14 Jul 2022

Adding erythropoietin to cooling therapy shows no added benefits for newborns with birth asphyxia

Adding erythropoietin to cooling therapy for term newborns with birth asphyxia has no benefit over cooling therapy alone, a study published today in the New England Journal of Medicine.

14 Jul 2022

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the current standard of chemotherapy alone.

14 Jul 2022

Stem cell transplantation produces prolonged survival with improved safety in patients with AL amyloidosis

AL amyloidosis is a life-threatening disease related to bone marrow cancer, multiple myeloma. It is caused when a person's antibody-producing white blood cells (i.e. plasma cells) do not function properly and generate abnormal protein which misfolds to form amyloid fibrils and deposits made of components of antibodies called light chains, which then deposit in various organs of the body.

14 Jul 2022

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announced eight outstanding research projects to receive its latest class of ASPIRE awards.

14 Jul 2022

Y chromosome loss in men can lead to deadly heart failure, research shows

The loss of the male sex chromosome as many men age causes the heart muscle to scar and can lead to deadly heart failure, new research from the University of Virginia School of Medicine shows.

14 Jul 2022

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Effective and safe treatments are needed for medulloblastoma - the most common type of cancerous brain tumor in children - especially for patients whose cancer has spread to the spinal cord.

14 Jul 2022

Video game intervention improves attention and executive functioning in patients with lupus

A National Jewish Health led study recently published in Lupus finds that technology through video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

14 Jul 2022

Integrating mental health support with routine care is essential for people with congenital heart defects

Although many individuals born with congenital heart defects develop resilience and have a high quality of life, they may face a variety of health-related psychological and social challenges throughout their lives.

14 Jul 2022

Hitting rewind on the spread of pancreatic cancer

News-Medical speaks to Linxiang Lan, a staff scientist at The Institute of Cancer Research, about a fundamental discovery that could pave way for new pancreatic cancer treatments.

14 Jul 2022

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Lung cancer is the deadliest form of cancer, accounting for an estimated 1.8 million deaths worldwide.

14 Jul 2022

Virtual reality app trial offers new hope for people suffering from phobias

Results from a University of Otago, Christchurch trial suggest fresh hope for the estimated one-in-twelve people worldwide suffering from a fear of flying, needles, heights, spiders and dogs.

14 Jul 2022

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

The NCRI Radiotherapy (CTRad) Group, a world-leading radiotherapy research group, has published its strategic priorities in radiotherapy research to address challenges in the field.

14 Jul 2022

Using microparticles to create 'self-boosting' vaccines

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

13 Jul 2022

Study uncovers a new defense mechanism used by the immune system to combat Candida infections

Of all the fungi that live in the human body, the most infamous is probably the yeast Candida. This distant cousin of baker's yeast is notorious for causing various types of thrush that can be a major nuisance, but it can also lead to an invasive infection that may, on occasion, prove fatal.

13 Jul 2022

New material for surgical dressings can be heated to kill melanoma cells but not other cells around it

Scientists from the University of Nottingham have combined graphene oxide, elastin, and ethanol to develop a new method to make this material conductive so it can be heated to kill melanoma cells but not other cells around it.

13 Jul 2022

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

Scientists assessed the potential of tixagevimab–cilgavimab for treating hospitalized SARS-CoV-2 patients.

13 Jul 2022

Does high-dose inhaled nitric oxide improve respiratory function and outcomes among pregnant patients hospitalized with severe COVID-19 pneumonia?

Researchers demonstrated that inhaled nitric oxide 200 (iNO200) enhances oxygenation in pregnant COVID-19 patients with severe pneumonia.

13 Jul 2022

How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?

Researchers evaluated the impact of the COVID-19 pandemic on the rates of pancreatic enzyme replacement therapy (PERT) prescribing in England.

13 Jul 2022

Therapy News and Research

New mouse model faithfully mimics brain damage caused by severe Rift Valley Fever virus infection

Pairing phone-based smoking cessation and lung screening programs could maximize health benefits, cut costs

Adding erythropoietin to cooling therapy shows no added benefits for newborns with birth asphyxia

Addition of brentuximab vedotin to chemotherapy has a positive impact for patients with Hodgkin lymphoma

Stem cell transplantation produces prolonged survival with improved safety in patients with AL amyloidosis

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

Y chromosome loss in men can lead to deadly heart failure, research shows

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Video game intervention improves attention and executive functioning in patients with lupus

Integrating mental health support with routine care is essential for people with congenital heart defects

Hitting rewind on the spread of pancreatic cancer

Study: Certain genetic features predispose lung cancer patients to develop immunotherapy side effects

Virtual reality app trial offers new hope for people suffering from phobias

NCRI CTRad publishes strategic priorities in radiotherapy research to improve patient outcomes

Using microparticles to create 'self-boosting' vaccines

Study uncovers a new defense mechanism used by the immune system to combat Candida infections

New material for surgical dressings can be heated to kill melanoma cells but not other cells around it

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

Does high-dose inhaled nitric oxide improve respiratory function and outcomes among pregnant patients hospitalized with severe COVID-19 pneumonia?

How has the COVID-19 pandemic impacted prescribing pancreatic enzyme replacement to people with unresectable pancreatic cancer?

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News